Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases
- PMID: 32203711
- PMCID: PMC7102637
- DOI: 10.1016/S2213-2600(20)30121-1
Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases
Abstract
WHO interim guidelines recommend offering extracorporeal membrane oxygenation (ECMO) to eligible patients with acute respiratory distress syndrome (ARDS) related to coronavirus disease 2019 (COVID-19). The number of patients with COVID-19 infection who might develop severe ARDS that is refractory to maximal medical management and require this level of support is currently unknown. Available evidence from similar patient populations suggests that carefully selected patients with severe ARDS who do not benefit from conventional treatment might be successfully supported with venovenous ECMO. The need for ECMO is relatively low and its use is mostly restricted to specialised centres globally. Providing complex therapies such as ECMO during outbreaks of emerging infectious diseases has unique challenges. Careful planning, judicious resource allocation, and training of personnel to provide complex therapeutic interventions while adhering to strict infection control measures are all crucial components of an ECMO action plan. ECMO can be initiated in specialist centres, or patients can receive ECMO during transportation from a centre that is not specialised for this procedure to an expert ECMO centre. Ensuring that systems enable safe and coordinated movement of critically ill patients, staff, and equipment is important to improve ECMO access. ECMO preparedness for the COVID-19 pandemic is important in view of the high transmission rate of the virus and respiratory-related mortality.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Figures


Comment in
-
Treatment for severe acute respiratory distress syndrome from COVID-19.Lancet Respir Med. 2020 May;8(5):433-434. doi: 10.1016/S2213-2600(20)30127-2. Epub 2020 Mar 20. Lancet Respir Med. 2020. PMID: 32203709 Free PMC article. No abstract available.
-
Blood transfusion strategies and ECMO during the COVID-19 pandemic - Authors' reply.Lancet Respir Med. 2020 May;8(5):e41. doi: 10.1016/S2213-2600(20)30174-0. Epub 2020 Apr 16. Lancet Respir Med. 2020. PMID: 32305077 Free PMC article. No abstract available.
-
Blood transfusion strategies and ECMO during the COVID-19 pandemic.Lancet Respir Med. 2020 May;8(5):e40. doi: 10.1016/S2213-2600(20)30173-9. Epub 2020 Apr 16. Lancet Respir Med. 2020. PMID: 32305078 Free PMC article. No abstract available.
-
Ethics and extracorporeal membrane oxygenation during coronavirus disease 2019 outbreak.Perfusion. 2020 Sep;35(6):562-564. doi: 10.1177/0267659120937545. Epub 2020 Jun 25. Perfusion. 2020. PMID: 32580648 No abstract available.
Similar articles
-
Extracorporeal Membrane Oxygenation for Severe Respiratory Failure During Respiratory Epidemics and Pandemics: A Narrative Review.Ann Acad Med Singap. 2020 Apr;49(4):199-214. Ann Acad Med Singap. 2020. PMID: 32296808 Review.
-
A Case of Extracorporeal Membrane Oxygenation as a Salvage Therapy for COVID-19-Associated Severe Acute Respiratory Distress Syndrome: Mounting Evidence.J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620957778. doi: 10.1177/2324709620957778. J Investig Med High Impact Case Rep. 2020. PMID: 32911986 Free PMC article.
-
Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).Med Sci Monit. 2020 Aug 6;26:e925364. doi: 10.12659/MSM.925364. Med Sci Monit. 2020. PMID: 32759887 Free PMC article. Review.
-
Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic.ASAIO J. 2020 Nov/Dec;66(10):1069-1072. doi: 10.1097/MAT.0000000000001251. ASAIO J. 2020. PMID: 33136589
-
Extracorporeal membrane oxygenation and COVID-19: The causes of failure.J Card Surg. 2020 Oct;35(10):2838-2843. doi: 10.1111/jocs.14867. Epub 2020 Jul 17. J Card Surg. 2020. PMID: 32678961 Free PMC article.
Cited by
-
Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization.ASAIO J. 2021 May 1;67(5):485-495. doi: 10.1097/MAT.0000000000001422. ASAIO J. 2021. PMID: 33657573 Free PMC article.
-
Opportunities and Challenges for Biosensors and Nanoscale Analytical Tools for Pandemics: COVID-19.ACS Nano. 2020 Jul 28;14(7):7783-7807. doi: 10.1021/acsnano.0c04421. Epub 2020 Jun 26. ACS Nano. 2020. PMID: 32551559 Free PMC article. Review.
-
Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review).Exp Ther Med. 2021 Apr;21(4):319. doi: 10.3892/etm.2021.9750. Epub 2021 Feb 3. Exp Ther Med. 2021. PMID: 33732292 Free PMC article. Review.
-
Veno-venous Extracorporeal Membrane Oxygenation Support in COVID-19 Respiratory Distress Syndrome: Initial Experience.ASAIO J. 2020 Jul;66(7):734-738. doi: 10.1097/MAT.0000000000001198. ASAIO J. 2020. PMID: 32597627 Free PMC article.
-
Modified endoscopic vacuum therapy for duodenal hemorrhage in patients with severe acute respiratory syndrome coronavirus 2.Endoscopy. 2022 Dec;54(S 02):E837-E839. doi: 10.1055/a-1803-4445. Epub 2022 May 13. Endoscopy. 2022. PMID: 35561983 Free PMC article. No abstract available.
References
-
- WHO Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. 2020. https://apps.who.int/iris/bitstream/handle/10665/330854/WHO-nCoV-Clinica...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources